Bayer Schering Pharma AG    



Muellerstr 178

Berlin, D-13342


49 030 46811 11

Company description

Manufacturing: Manufacture of and trade in medicaments and pharmaceuticals; research. The four strategic business areas are: gynecology and andrology, specialized therapeutics, diagnostics and radiopharmaceuticals, dermatology

Log in for comprehensive information about this and hundreds of thousands of other companies.

News and information about Bayer Schering Pharma AG

Research and Markets Adds Report: Biobanking: Technologies and Global Markets
Health & Beauty Close-Up; December 7, 2016; 615 words
...discussed in this report. Companies Mentioned: -Abbott Laboratories -Affymetrix -Asterand Plc -Astrazeneca -Bayer Schering Pharma Ag -Biochain-Genomics -Biostorage Technologies -Boehringer Ingelheim Gmbh -Bristol-Myers Squibb Co -Daiichi...
Wipo Publishes Patent of Martin F. Hentemann, William Scott, Jill Wood, Jeffrey Johnson, Aniko Redman, Ann-Marie Bullion, Leatte Guernon and Bayer Schering Pharma for "Sulfone Substituted 2,3-Dihydroimidazo [1,2-C] Quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases with Angiogenesis" (American Inventors)
US Fed News Service, Including US State News; March 27, 2016; 454 words
...DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES WITH ANGIOGENESIS."Applicants: Bayer Schering Pharma AG (DE), Martin F. Hentemann (US), William Scott (US), Jill Wood (US), Jeffrey Johnson (US), Aniko...
Germany : Werner Baumann to Succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer AG
Mena Report; February 26, 2016; 700+ words
...also serving as the company's Labor Director. As a member of the Board of Management and Labor Director of Bayer Schering Pharma AG, Berlin, Germany, from 2006 through September 2009, his roles included actively participating in this companys...
MRI for Discriminating Metastatic Ovarian Tumors from Primary Epithelial Ovarian Cancers
Journal of Ovarian Research; August 28, 2015; 700+ words
...and a power injector (Missouri Ulrich, Ulm, Germany) was used to inject the contrast medium (Magnevist, Bayer Schering Pharma AG, Germany). The parameters of the LAVA MRI protocol were: TR?=?3.5?ms; TE?=?1.6?ms; NEX...
The Intratumoral Administration of Ferucarbotran Conjugated with Doxorubicin Improved Therapeutic Effect by Magnetic Hyperthermia Combined with Pharmacotherapy in a Hepatocellular Carcinoma Model
Journal of Experimental & Clinical Cancer Research; July 18, 2014; 700+ words
...humans because their safety and toxicity have not been clearly documented. However, ferucarbotran (Resovist; Bayer Schering Pharma AG, Leverkusen, Germany) is a clinically-approved superparamagnetic iron oxide nanoparticle that has been...
A Comparative Study of Neurotoxic Potential of Synthesized Polysaccharide-Coated and Native Ferritin-Based Magnetic Nanoparticles
Croatian Medical Journal; June 1, 2014; 700+ words
...Contrast agents based on dextran-coated iron oxides, eg, Endorem (Guerbet, Roissy, France) and Resovist (Bayer Schering Pharma AG, Berlin-Wedding, Germany), have been commercially available for human use as blood pool agents. Similarly...
Syndax Maps out IPO to Fund Metastatic Breast Cancer Candidate
BIOWORLD Today; March 31, 2014; 700+ words
...managers. Syndax in-licensed global rights to the oral selective histone deacetylase from Berlin-based Bayer Schering Pharma AG in 2007. It is obligated to pay Bayer up to $50 million upon reaching certain milestones in the development...
US Patent Issued to Bayer Schering Pharma on March 25 for "5-[(3,3,3-Trifluoro-2-Hydroxy-1-Arylpropyl)amino-1 H -Quinolin-2-ones, a Process for Their Production and Their Use as Anti-Inflammatory Agents" (German Inventors)
US Fed News Service, Including US State News; March 25, 2014; 375 words
...ALEXANDRIA, Va., March 25 -- United States Patent no. 8,680,117, issued on March 25, was assigned to Bayer Schering Pharma AG (Berlin)."5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino-1 H -quinolin-2-ones...

Search HighBeam Business for more news about Bayer Schering Pharma AG

Industry information

NAICS codes 
North American Industry Classification System (NAICS) codes are used to classify businesses for the purpose of collecting statistical data related to the U.S. economy. NAICS codes have been assigned to international companies to help organize all companies by type of activity.  

Primary: 325412 - Pharmaceutical Preparation Manufacturing

325411 - Medicinal and Botanical Manufacturing

325413 - In-Vitro Diagnostic Substance Manufacturing

325414 - Biological Product (except Diagnostic) Manufacturing

424210 - Drugs and Druggists' Sundries Merchant Wholesalers


SIC codes 
Standard Industrial Classification (SIC) codes classify establishments by their primary type of activity. SIC codes are a U.S. Census Bureau system but can apply to international companies.  

Primary: 2834 - Pharmaceutical Preparations industry report

2833 - Medicinal Chemicals and Botanical Products industry report

2835 - In Vitro and In Vivo Diagnostic Substances industry report

2836 - Biological Products, Except Diagnostic Substances industry report

5122 - Drugs, Drug Proprietaries, and Druggists' Sundries industry report